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Phagocytosis of IgG-opsonized pathogens by Fc receptors
requires extensive remodeling of the actin cytoskeleton, a proc-
ess regulatedby the smallGTPaseRac.Vavwas thought tobe the
guanine nucleotide exchange factor responsible for the activa-
tion of Rac, but recent evidence indicates that Fc receptor-
mediated phagocytosis is unaffected in macrophages lacking all
three isoforms of Vav. We therefore tested whether another
GEF,DOCK180, participates in Fc receptor-initiated phagocy-
tosis. DOCK180 associates with the adaptor protein Crk, which
mediates recruitment of the GEF to sites of tyrosine phospho-
rylation. CrkII and DOCK180 were found to accumulate at the
phagocytic cup. Knockdown of Crk or DOCK180 in murine
macrophages using small interfering RNA inhibited phagocyto-
sis of IgG-opsonized particles. Moreover, transfection of domi-
nant negative CrkII prevented both recruitment of DOCK180
and the activation of Rac at the phagocytic cup. This is the first
report of a role for either Crk or DOCK180 in Fc receptor-
mediated phagocytosis. TheCrk-DOCK180 complex is involved
in the clearance of apoptotic cells, which unlike the ingestion of
IgG-opsonized particles, is an anti-inflammatory process. The
finding that CrkII-DOCK180 is also responsible, at least in part,
for the effects of Fc receptors implies that additional, parallel
pathwaysmustaccount for theassociatedpro-inflammatoryeffect.
Phagocytosis is a key component of the innate immune
response to infection. Phagocytic receptors recognize molecular
features inherent to infectious microorganisms or bind host-de-
rived opsonins, such as complement components or immuno-
globulins that coat their surface. Fc receptors on the surface of
phagocytes recognize pathogens opsonized by IgG. Upon engage-
ment, the receptors become phosphorylated by Src family kinases
and recruit and activate the kinase Syk (1). These early events cul-
minate in extensive remodeling of the actin cytoskeleton, which is
essential for engulfment of the pathogen.
Actin restructuring during Fc-mediated phagocytosis is reg-
ulated by the small GTPases Cdc42 andRac. TheseGTPases act
as molecular switches, recruiting effector proteins only when
bound to GTP, a condition promoted by guanine nucleotide
exchange factors (GEFs).4 The activation cycle is terminated by
hydrolysis of GTP, which is facilitated by GTPase activating
proteins. Although the relative contributions of Rac and Cdc42
to Fc-mediated phagocytosis are only partially understood (2),
there is good evidence that Rac plays an essential role. Epitope-
tagged Rac becomes enriched at sites of Fc-mediated phago-
cytosis (3), whereas expression of dominant negative Rac con-
structs drastically inhibits phagocytosis and the accumulation
of actin underneath the IgG-opsonized particle (4). Indeed,
recruitment of active Rac to the plasma membrane per se is
sufficient to induce phagocytosis of latex beads (5).
Despite its importance, it remains unclear how stimulation
of Fc receptors is linked to Rac activation. In particular, the
identity of the GEF(s) responsible for activating Rac is contro-
versial. Some evidence has implicated Vav isoforms, because
microinjection of dominant negative Vav constructs was found
to inhibit phagocytosis of IgG-opsonized red blood cells (6). On
the other hand, it has recently been shown that macrophages
deficient in all three isoforms of Vav display no defect in Fc-
mediated phagocytosis (7).
It is known that GEFs can be recruited to receptors at the
plasma membrane by adaptor proteins (8). Such adaptors con-
tain modular protein-protein interaction domains that allow
the activated receptor to recruit downstream signaling mole-
cules (9). One such adaptor, CrkII, contains anN-terminal SH2
domain that interacts with phosphorylated tyrosine residues
followed by two SH3 domains (designated SH3-N and SH3-C)
that bind proline-rich motifs (10). Interestingly, in Caenorhab-
ditis elegans, CED-2 (the homologue of CrkII) has been shown
to mediate phagocytic clearance of apoptotic cells (11) and
interacts with a Rac GEF, DOCK180, via its SH3-N domain.
Recently, CrkII was also found to be essential for the invasion of
Listeria monocytogenes into non-phagocytic mammalian cells
(12). Whether CrkII is also necessary for Fc-mediated phago-
cytosis is unknown.
In this work, we sought to determine the link between the
early events in Fc receptor-mediated signaling and Rac activa-
tion in macrophages. We identified a critical role for CrkII in
the phagocytosis of IgG-opsonized particles and provided evi-
dence that this adaptor serves to recruit the RacGEFDOCK180
to the site of ingestion. CrkII-DOCK180-mediated activation of
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Rac therefore represents a conserved signaling pathway com-
mon to the phagocytosis of both IgG-opsonized particles and
apoptotic cells.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Fetal bovine serum, Dulbecco’s
modified Eagle’s medium,Hepes-buffered solution/RPMI 1640
and phosphate-buffered saline (PBS) were from Wisent
(St. Bruno, Quebec, Canada). Latex beads (3.1 m in diameter)
were from Bangs Beads (Fishers, IN). Mouse monoclonal anti-
body to Crk was from BD Biosciences. Goat antibody to
DOCK180 and rabbit anti-CrkLwere fromSantaCruz Biotech-
nology (SantaCruz, CA).Mousemonoclonal anti-HAwas from
Covance (Berkeley, CA). Rat anti-mouse CD16/CD32was from
BD Biosciences. Mouse monoclonal anti-phosphotyrosine anti-
body was from Upstate Biotechnology (Lake Placid, NY) and
mouse monoclonal anti-GAPDH was from Chemicon Interna-
tional (Temecula, CA). Mouse monoclonal anti-FLAG, human
IgG, LY294002, and all other reagents were from Sigma-Aldrich
Canada (Oakville, Ontario).
DNA Constructs—The small interfering RNA (siRNA) pool
used to silence Crk consisted of the combination of four differ-
ent double-stranded oligonucleotides: 1) sense, 5-U-C-C-C-
U-U-A-C-G-U-G-G-A-G-A-A-G-U-A-U-U-3; antisense, 5-
P-U-A-C-U-U-C-U-C-C-A-C-G-U-A-A-G-G-G-A-U-U-3; 2)
sense, 5-C-C-G-A-A-U-A-G-G-A-G-A-U-C-A-A-G-A-A-U-
U-3; antisense 5-P-U-U-C-U-U-G-A-U-C-U-C-C-U-A-U-
U-C-G-G-U-U-3; 3) sense, 5-C-A-G-A-A-G-C-G-A-G-U-C-
C-C-U-A-A-U-G-U-U-3; antisense, 5-P-C-A-U-U-A-G-G-G-
A-C-U-C-G-C-U-U-C-U-G-U-U-3; and 4) sense, 5-G-U-U-A-
C-G-A-A-G-A-U-U-A-A-U-G-U-G-A-U-U-3; antisense, 5-P-
U-C-A-C-A-U-U-A-A-U-C-U-U-C-G-U-A-A-C-U-U-3. The
siRNA pool to Crk (siGENOME SMARTpool M-061117) and
the non-targeting siRNA control (siCONTROL Non-targeting
siRNA#1 D-001210–01) were from Dharmacon (Lafayette,
CO), and siRNA toDOCK180 (SC-35208) was from Santa Cruz
Biotechnology. Plasmids encoding enhanced green fluorescent
protein-DOCK180 and FLAG-DOCK180were generously pro-
vided by Dr. M. Matsuda (Osaka University, Japan). The plas-
mids encoding HA-tagged wild-type and dominant negative
CrkII (R38K, W170K, W276K) have been previously described
(12, 13). The plasmid encoding the fusion of the PBD-YFP was
a gift of Dr. G. Bokoch (The Scripps Research Institute, La Jolla,
CA).
Cell Culture and Transfection—RAW264.7 cells were
obtained from the American Type Culture Collection (Manas-
sas, VA) and were grown in Dulbecco’s modified Eagle’s
mediumwith 5% fetal bovine serum at 37 °C in 5%CO2 under a
humidified atmosphere. Lipofection was carried out with
FuGENE-6 transfection reagent (Roche Diagnostics) using 5l
of the lipofection reagent and 2 g of DNA. Electroporation
was performed using the Amaxa system (Cologne, Germany),
following the manufacturer’s guidelines, with 2 million cells
and either 2g of cDNAor 1.5g of siRNAusing programD32.
Cells were analyzed 6–10 h after electroporation, unless other-
wise stated.
Human macrophages were isolated by plating the lympho-
cyte/monocyte-rich layer of blood from healthy volunteers on
coverslips bathed in Dulbecco’s modified Eagle’s medium with
10% fetal bovine serum, incubating them at 37 °C, followed by
washing with sterile PBS and changing the medium daily for
five days to remove platelets and lymphocytes.
Phagocytosis Assays—Latex beads were opsonized with 3.75
mg/ml human IgG for 1 h at 37 °C. Cells grown on glass cover-
slips were changed to prewarmed serum-free Hepes-buffered
solution/RPMI 1640 and were overlaid with 25 l of opsonized
latex beads and incubated at 37 °C to initiate phagocytosis. In
most experiments, phagocytosis was synchronized by centrifu-
gation of the beads onto the cells at 1500 revolutions/min for
10 s. Unless stated otherwise, RAW cells were incubated with
beads for 10 min at 37 °C followed by labeling of external beads
using Cy5-conjugated donkey anti-human antibody and then
fixed with 4% paraformaldehyde. In some experiments, RAW
cells were pretreated with 100MLY294002 for 15min prior to
phagocytosis.
Microscopy, Immunofluorescence, and Image Analysis—
Analysis of the distribution and density of Crk, DOCK180, and
PBD-YFP was performed using an LSM510 laser scanning con-
focal microscope (Zeiss) with a 100 oil immersion objective.
Quantitation of the fluorescence of PBD-YFP at the phagoso-
mal cup was accomplished using Image J software (NIH) after
subtracting for the background.Membrane-associated fluores-
cencewas normalized to cytosolic fluorescence to eliminate the
variable expression inherent to transient transfection. The
phagocytic index of cells transfected with dominant negative
mutants of CrkII was calculated by imaging random fields and
counting the number of internalized beads in cells express-
ing suitably high levels of the transfected gene product.
Phagocytic index of cells treated with siRNA was calculated
by imaging random fields and counting the number of inter-
nalized beads divided by the number of cells in the field. In all
cases, image acquisition settings were kept constant between
conditions.
Immunofluorescence of Crk in RAW cells was performed by
fixing cells in 4% paraformaldehyde followed by permeabiliza-
tion in 0.1% Triton, blocking in 5%milk, and then probing with
mouse anti-Crk at 1:100 for 1 h. After washing with PBS, the
samples were incubated with Cy-3-conjugated anti-mouse
antibody (1:1000) for 30 min and then washed and mounted
using DAKOmountingmedium (Dako Cytomation, Carpente-
ria, CA). An identical procedure was used for immunofluores-
cence of DOCK180 in RAW cells, except that a goat anti-
DOCK180 primary antibody (1:50) and the appropriate
secondary antibody were used. For immunofluorescence of
HA- or FLAG-tagged proteins, we used mouse anti-HA at
1:1000 and mouse anti-FLAG at 1:1000 for 1 h.
Flow Cytometry—RAWcells were treated with siRNA to Crk
or control siRNA72hbefore the experiment. Cells were probed
with Fc Block antibody according to the manufacturer’s
instructions (BD Biosciences) using a Cy2-conjugated second-
ary antibody at 1:1000. Cells were analyzed in a FACS-Calibur
cytometer (BD Biosciences), and the results were analyzed
using FlowJo software (Tree Star Flow Jo).
Immunoblotting—Lysates were analyzed by SDS-PAGE
using 7–10% polyacrylamide gels. Proteins were transferred to
nitrocellulose membranes, blocked for 1 h in 5% milk in PBS
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with 0.05% Tween 20 (PBS/Tween), and then probed overnight
with the primary antibody at 4 °C. We used 1:2500 for mouse
anti-Crk, 1:100 for anti-DOCK180, 1:50 for anti-CrkL, 1:2000
for anti-GAPDH, and 1:10000 for anti-phosphotyrosine anti-
bodies. After washing in PBS/Tween, the blots were incubated
with horseradish peroxidase-conjugated secondary antibodies
(1:2000–1:5000) for 30 min, washed vigorously, and then
visualized by enhanced chemiluminescence (Amersham
Biosciences).
Aggregated IgG was prepared by heating a 12.5 mg/ml solu-
tion of IgG in PBS to 56 °C for 30 min and then removing high-
molecular-weight aggregates by centrifugation. The superna-
tant was applied to the cells for 7 min at 37 °C. For
immunoblotting for phosphotyrosine, membranes were
blocked with 0.5% bovine serum albumin in Tris-buffered
saline (TBS), and washes were in TBS with 0.1% Tween 20.
Quantitation of protein bands was performed using Image J
(NIH) on scanned blots and included correction for the
background.
Protein Expression, Purification, and Pulldown Assay—Plas-
mid constructs containing glutathione S-transferase (GST)
alone or fused to full-length wild-type CrkII or CrkII W170K
were expressed in Escherichia coli and purified as described
previously (12). Sedimentation of proteins from solubilized
lysates of RAWcells that interact with GST fusion proteins was
performed essentially as previously described (12). Approxi-
mately 2 106 RAW cells were seeded in 10-cm plates and
grown for 24 h. The cells were rinsed with ice-cold PBS and
solubilized by the addition of 1 ml of ice-cold lysis buffer (1%
Triton X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 3 mM
sodium-orthovanadate HCl-activated, 20mMNaF, 1mM phen-
ylmethylsulfonyl fluoride, and 10 g/ml each of aprotinin and
leupeptin). The RAW cell lysate was centrifuged at 12,000 g
for 10 min at 4 °C, and the supernatant was recovered and used
for the pulldown assay. Equal quantities of GST fusion proteins
andRAWcell lysateswere used for each precipitation. The total
protein in the precipitates was separated on 8% SDS-polyacryl-
amide gels and analyzed by immunoblotting for DOCK180.
Statistics—Unless otherwise stated, all experiments were per-
formed at least in triplicate. For comparisons of means, Student’s
t tests were used. A probability0.05 was deemed significant.
RESULTS
CrkII Is Recruited to the Phagocytic Cup during Fc-mediated
Phagocytosis—To confirm that Crk is expressed in macro-
phages, we analyzed whole cell lysates of human blood mono-
cyte-derived macrophages and murine RAW264.7 cells (here-
after called RAWcells) by immunoblotting using amonoclonal
antibody that recognizes the two known splice variants of Crk
(10). As expected, we detected two bands, corresponding to
CrkII (40 kDa) and CrkI (28 kDa). As shown in Fig. 1A,
CrkII is expressed at higher levels than CrkI in both human and
murine macrophages. Next, we determined whether Crk is
recruited to the phagosomeduring Fc-mediated phagocytosis.
Human macrophages were allowed to ingest IgG-opsonized
latex beads and were subsequently immunostained for endog-
enous Crk. A distinct recruitment of Crk to the nascent phago-
some was noted (Fig. 1B). A similar recruitment was also
observed in RAWmacrophages (Fig. 1C), indicating that Crk is
present and mobilizes to phagosomes in both human and
murine phagocytes. Of note, the association of endogenous Crk
was clearly observable at the earliest stages of phagocytic cup
formation but was virtually absent from formed (sealed) pha-
gosomes (Fig. 1D). The accumulation of Crk at the phagocytic
FIGURE 1. CrkII is recruited to the cup during Fc receptor-mediated
phagocytosis. A, whole cell lysates from murine (RAW264.7) or human pri-
mary macrophages were probed for Crk by immunoblotting. The top and
bottom bands correspond to CrkII and CrkI, respectively. The positions of 37
and 25 kDa molecular weight markers are indicated. B, primary human mac-
rophages were incubated with IgG-opsonized latex beads for 1 min at 37 °C
and probed for endogenous Crk. The inset is a corresponding differential
interference contrast (DIC) image. For all images, arrows denote phagocytic
cups, asterisks denote positions of beads, and scale bar represents 3 m.
C, RAWcells incubatedwith IgG-opsonized latexbeads for 1min at 37 °Cwere
probed for endogenous Crk by immunostaining.D, RAW cells incubatedwith
IgG-opsonized latexbeads for 5minat 37 °Cwereprobed for endogenousCrk
by immunostaining. E, RAW cells were transfected with HA-tagged CrkII and
incubated with IgG-opsonized latex beads for 1 min followed by immuno-
staining for HA. Bottom panel represents XZ reconstruction, and the inset is a
DIC image. F, RAWcells were transfectedwithHA-taggedCrkII and incubated
with IgG-opsonized latex beads for 5 min followed by immunostaining for
HA. Images are representative of at least three separate experiments of each
type.
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cup was also apparent in RAW cells transfected with
HA-taggedCrkII, the predominant splice isoform in these cells.
As found for endogenousCrk, the recruitment of CrkII-HAwas
noticeable during the initial stages of phagocytosis (Fig. 1E), but
despite the improved detectability conferred by the epitope tag,
the adaptor protein was virtually absent from sealed phago-
somes (Fig. 1F). These data demonstrate that CrkII is recruited
rapidly to the forming phagosome in both murine and human
macrophages but suggest that this recruitment is only transient.
DominantNegative CrkII Inhibits Fc-mediated Phagocytosis—
To determine the functional role of CrkII in phagocytosis, we
expressed dominant negative mutant forms of the adaptor in
RAW macrophages. These mutants have amino acid substitu-
tions in either the SH2 (R38K), SH3-N (W170K), or SH3-C
(W276K) domains of the protein (Fig. 2A). The R38Kmutation
eliminates an arginine residue found in all SH2 domains that is
known to be essential for the recognition of phosphotyrosine
groups (13). Similarly, the W170K andW276K mutations alter
conserved tryptophans required for binding of SH3 domains to
proline-rich motifs (14). Mutants of CrkII at Arg-38 and Trp-
170 have been previously shown to disrupt the interaction of
CrkII with its binding partners (15). Transfection of the domi-
nant negative mutants of CrkII significantly inhibited phagocy-
tosis, with the greatest inhibition occurring with the R38K and
W170K mutants (Fig. 2B; p 0.01 for all mutants versus con-
trol). In particular, expression of the R38K mutant decreased
phagocytosis by almost 75% relative to cells transfected with
wild-type CrkII. This mutant also decreased the ability of the
cells to spread on the substratum (not illustrated), consistent
with an effect on actin remodeling. Transfection of wild-type
CrkII had no significant effect on internalization compared
with untransfected cells (data not shown).
Knockdown of Crk by siRNA Inhibits Fc-mediated Phago-
cytosis—Because overexpression of inhibitory mutants can
have undesirable effects on related yet distinct pathways, we
sought to confirm the role of Crk by alternative, more specific
means. To this end, we introduced siRNA to Crk into RAW
cells by electroporation anddetermined the levels of the protein
48–72 h later. As a control for our siRNA studies, we used a
non-targeting siRNA (Dharmacon, Lafayette, CO) specifically
designed not to interact with any gene products in mouse cells.
Although Crk expression was unaffected in cells transfected
with control siRNA, the expression of both isoforms wasmark-
edly depressed in cells treated with Crk siRNA. CrkI and CrkII
protein levels dropped by75 and 50%, respectively (p 0.05
versus control for both) (Fig. 3A and B). Importantly, this effect
was specific to the Crk gene. Not only was the expression of
unrelated housekeeping proteins such as GAPDH unaffected,
FIGURE 2. Dominant negative CrkII inhibits Fc-mediated phagocytosis.
A, schematic of the domain structure of CrkII and of the mutants used in this
study. B, quantitation of the effect of CrkII dominant negativemutants on the
phagocytic index. RAWmacrophages were transfected with either wild-type
(WT) or dominant negative alleles of HA-tagged CrkII before incubation with
IgG-opsonized latex beads. The phagocytic index was calculated relative to
cells transfected with wild-type CrkII. Data are means S.E. of at least 70
individual determinations/condition.
FIGURE 3.Knockdownof Crk by siRNA inhibits Fc-mediated phagocyto-
sis. A, RAW cells were treated with siRNA to Crk, and lysates were probed by
immunoblotting for Crk 48–72 h later. Blots were stripped and reprobed for
GADPH as a loading control (Ctrl) followed by stripping and reprobing for
CrkL. B, quantitation of protein knockdown. Blots such as that in A were
scanned, and the intensity of the bands was normalized to control cells after
background subtraction. Data are means S.E. of three separate experi-
ments. RAW cells treated with either control siRNA (C and D) or siRNA to Crk
(E and F) were incubated with IgG-opsonized beads 48–72 h after electropo-
ration and then immunostained using an antibody to Crk (red). Non-internal-
ized beads were detected using Cy5-conjugated anti-human antibody and
are shown in blue. Corresponding DIC images are shown in D and F. G, quan-
titation of the effect of knockdown of Crk on the phagocytic index. RAW cells
treated with either control siRNA or siRNA to Crk for 48–72 h were incubated
with IgG-opsonized beads. The phagocytic index was normalized to the con-
trol cells. Data represent means S.E. from three separate experiments and
1300 cells/condition.
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but the levels of the related protein CrkL were similarly unal-
tered (Fig. 3A).
In parallel experiments, we exposed siRNA-transfected cells
to IgG-opsonized beads and determined the phagocytic index
(Fig. 3,C–F). Cells pretreated with Crk siRNA had a lower abil-
ity to ingest particles compared with non-targeting siRNA con-
trols (Fig. 3G). The inhibition was never complete, but it was
highly significant (p 0.01) and of the same order as the reduc-
tion in protein expression (see above). This likely reflects het-
erogeneity in the delivery of siRNA by electroporation, because
immunostaining revealed the presence of two populations of
cells: one with near-normal expression and another with negli-
gible levels (not shown). Together with the data from the dom-
inant negative constructs, these results indicate that Crk has an
essential function in Fc-mediated phagocytosis.
Knockdown of Crk Does Not Affect Fc Receptor Levels or
Function—Silencing the Crk gene was expected to alter the
adaptor function of this protein and its downstream effectors
without impairing receptor activation. To validate this notion,
we determined the surface density and activation state of Fc
receptors in cells treated with control or Crk-directed siRNA.
Flow cytometric determinations revealed that the surface
expression of Fc receptors was indistinguishable in control
and Crk-depleted cells (Fig. 4A). The ability of these receptors
to become activatedwas evaluated by quantifying the induction
of tyrosine phosphorylation triggered by cross-linking. As
shown in Fig. 4B, a robust increase in phosphotyrosine content
was induced by aggregated IgG in both control and Crk-de-
pleted cells. These results provide evidence that Crk knock-
downdoes not affect Fc receptor expression, targeting, or acti-
vation and imply that Crk plays a specific role in signaling
subsequent transduction events.
DOCK180 Is Recruited to the Phagocytic Cup in a CrkII-de-
pendent Manner—One of the best-characterized Crk-binding
proteins is DOCK180, which was described to display GEF
activity (16, 17). It therefore seemed conceivable that CrkII
functions at the nascent phagocytic cup by recruiting
DOCK180. To test this hypothesis, we immunostained endog-
enous DOCK180 in RAW macrophages during the course of
phagocytosis of IgG-opsonized beads (Fig. 5A). We also trans-
fected RAWmacrophages with either FLAG- or green fluores-
cent protein (GFP)-tagged DOCK180 and visualized the cells
during the course of particle ingestion. An obvious accumula-
tion of DOCK180 at the cup was observed very early during
phagocytosis, whether by immuno-
staining of the endogenous protein
or of epitope-tagged constructs (Fig.
5, B and C), resembling the pattern
noted earlier with CrkII.
DOCK180 binds to Crk through
a C-terminal proline-rich motif
that is recognized by an SH3
domain of the adaptor (16). In
addition, DOCK180 possesses a
DHR-1 domain that binds phos-
phatidylinositol 3,4,5-trisphosphate
(PIP3) (18). To analyze the contribu-
tion of the DHR-1 domain to
DOCK180 recruitment to the pha-
gosome, we pretreated RAW cells
with LY294002, a potent and spe-
cific inhibitor of phosphatidylinosi-
tol 3-kinase, the enzyme that gener-
ates PIP3. Pretreatment for 15 min
with the inhibitor at a concentration
of 100Mwas sufficient to eliminate
the formation of PIP3 at the phago-
cytic cup, as monitored using the
pleckstrin homology (PH) domain
FIGURE 4. Knockdown of Crk does not affect Fc receptor expression or
function. A, RAW cells treated with either control (Ctrl) siRNA or siRNA to Crk
were probed 72 h after electroporation with an antibody to murine FcRII/III
followed by a Cy2-labeled secondary antibody and then analyzed by flow
cytometry. Black tracing denotes cells treated with siRNA to Crk; gray tracing
denotes control siRNA-treated cells. Histogram is representative of three sep-
arate experiments. B, RAW cells treated with either control or Crk-specific
siRNA were stimulated 72 h after electroporation with aggregated IgG for 7
min at 37 °C and then analyzed by immunoblotting. Lysates were probed
using an anti-phosphotyrosine antibody and then stripped and reprobed for
GAPDH as a loading control. Images and blots are representative of two inde-
pendent experiments.
FIGURE 5.DOCK180 is recruited to the cup in a CrkII-dependentmanner. A, RAW cells were incubatedwith
IgG-opsonized beads for 1min at 37 °C and then probed for endogenous DOCK180. For all panels, arrowheads
denote the phagocytic cup, whereas asterisks denote beads. Insets are correspondingDIC images. B, RAW cells
were transfectedwith FLAG-taggedDOCK180 and incubatedwith IgG-opsonized beads for 1min at 37 °C and
then probed for the FLAG epitope. C, RAW cells were transfected with GFP-tagged DOCK180 and incubated
with IgG-opsonizedbeads for 1min and then visualizedby confocalmicroscopy.D, RAWcellswere transfected
with GFP-tagged DOCK180 and treated with 100 M LY294002 for 15 min prior to incubation with IgG-opso-
nized beads for 1 min. RAW cells were co-transfected with GFP-tagged DOCK180 (E) and HA-tagged CrkII and
incubated with IgG-opsonized beads for 1 min followed by immunostaining for HA (F). RAW cells were co-
transfectedwithGFP-taggedDOCK180 (G) andHA-taggedCrkII(R38K) and then incubatedwith IgG-opsonized
beads for 1 min followed by immunostaining for HA (H). Images are representative of three separate
experiments.
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of Akt linked to GFP (Akt-PH-GFP) (19, 20) (data not shown).
Recruitment of DOCK180 to the cup persisted under these
conditions (Fig. 5D), implying that the interaction between
PIP3 and the DHR-1 domain is dispensable and suggesting that
association through CrkII may be more important.
Accordingly, when RAW cells were co-transfected with
GFP-DOCK180 and HA-tagged CrkII, we observed a high
degree of colocalization of these proteins at the phagocytic cup
using confocal microscopy (Fig. 5, E and F). To determine
whether the recruitment of DOCK180 was in fact mediated by
CrkII, RAW cells were co-transfected with the HA-tagged
CrkII(R38K). This mutation disrupts the ability of the SH2
domain in CrkII to interact with phosphotyrosines at sites of
receptor activation and, as a result, CrkII(R38K) was not
recruited to the phagocytic cup (Fig. 5H). Importantly, expres-
sion of the dominant negative CrkII blocked recruitment of
DOCK180 to sites of phagocytosis (Fig. 5, compare G with E).
We further assessed the association of CrkII and DOCK180
by carrying out GST pulldown assays on protein extracts
obtained from RAW cells. Pulldown experiments showed that
GST-CrkII, a fusion protein constructed using the full-length
wild-type form of CrkII, interacts directly with DOCK180, as
previously reported (16). In contrast, GST-CrkII(W170K), a
fusion of GST with a form of CrkII bearing a point mutation in
the SH3 domain that binds DOCK180, failed to pull down
DOCK180 as did GST alone (Fig. 6). Together, these data sug-
gest that DOCK180 is recruited to the phagocytic cup by CrkII.
Knockdown of DOCK180 by siRNA Inhibits Fc Receptor-me-
diated Phagocytosis—To assess the importance of CrkII-
DOCK180 signaling to phagocytosis, we treated RAW cells
with siRNA to DOCK180. Immunoblotting performed 72 h
after transfection showed that the expression of DOCK180 had
decreased by almost 50% compared with cells exposed to con-
trol siRNA (p 0.001) (Fig. 7, A and B). No further decrease in
the content of DOCK180 was achieved with longer treatments
with siRNA, probably reflecting the incomplete nature of the
transfection protocol. Nonetheless, in parallel experiments
where the phagocytic index of siRNA-treated cells was meas-
ured, depletion of DOCK180 caused a significant impairment
of Fc-mediated phagocytosis relative to controls (p 0.05)
(Fig. 7C).
CrkII and DOCK180 Are Required for the Recruitment of
Active Rac to the Phagocytic Cup—Our findings suggested that
CrkII-DOCK180 signaling is required for Fc-mediated phag-
ocytosis. DOCK180 is the founding member of a newly recog-
FIGURE 6. CrkII and DOCK180 interact directly. Identical volumes of RAW
cell lysateswere used for precipitationwith equal amounts of either GST or of
the indicated fusion proteins. GST-CrkII(WT) is a fusion of GSTwith full-length
wild-type CrkII. GST-CrkII(W170K) is a fusion of GST with a point mutant of
full-length CrkII. Precipitates were subjected to SDS-PAGE on 8% gels, and
DOCK180 was detected by immunoblotting with anti-DOCK180 antibodies.
Equal loading of the fusion proteins was verified independently by staining
the blots with FastBlot (not shown). The blot is representative of three similar
experiments.
FIGURE 7. Knockdown of DOCK180 inhibits Fc-mediated phagocytosis. A, RAW cells were treated with siRNA to DOCK180 (or control (Ctrl) siRNA), and
lysates were probed by immunoblotting for DOCK180 72 h after electroporation. Blots were stripped and reprobed for GADPH as a loading control.
B, quantitation of protein knockdown. Blots such as that in A were scanned, and the intensity of bands was normalized to the control cells after background
subtraction. Data represent means S.E. from three independent experiments. C, quantitation of the effect of knockdown of DOCK180 on the phagocytic
index. RAW cells treated with either control or DOCK180-specific siRNA were incubated with IgG-opsonized beads 72 h after electroporation. The phagocytic
index was normalized to control cells. Data represent means S.E. from three separate experiments and include800 cells/condition.
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nized family of GEFs that do not possess a Dbl domain (8).
Instead, DOCK180 has a DHR-2 or DOCKER domain capable
of loading Rac (but not Rho or Cdc42) with GTP (17, 21). We
therefore tested whether DOCK180 recruitment via CrkII con-
tributes to the activation of Rac in forming phagosomes. RAW
cells were co-transfected with CrkII(R38K) and YFP-tagged
PBD. The latter construct consists of the p21 Rac-GTP-binding
domain of PAK fused to YFP and is a sensitive indicator of Rac
activity (22). In cells co-transfected with wild-type CrkII and
PBD-YFP, the Rac-GTP indicator was recruited to phagocytic
cups, as expected (Fig. 8, A and B). In contrast, co-transfection
with the dominant negative CrkII(R38K) completely ablated
the accumulation of PBD-YFP at the cup (Fig. 8, C–E). These
data indicate that functional CrkII is required for Rac activation
at sites of Fc receptor-initiated phagocytosis.
Additionally, we tested whether DOCK180 was directly
involved in Rac activation. RAW cells were treated with siRNA
toDOCK180 and 48 h laterwere transfected by lipofectionwith
the Rac-GTP indicator, YFP-tagged PBD. Co-transfection with
siRNAand the PBD-YFPwas not feasible due to the progressive
loss of expression of the PBD-YFP over periods 24 h after
transfection. ThePBD-YFP accumulation at the phagocytic cup
was assessed after 72 h of treatment with siRNA. The depletion
of DOCK180 prevented the accumulation of the Rac-GTP indi-
cator at the phagocytic cup, which was readily observed in cells
treated with control (non-targeting) siRNA (Fig. 9). These data
suggest that DOCK180 is necessary for Rac activation at sites of
Fc receptor-mediated phagocytosis.
DISCUSSION
This report describes a role for CrkII and DOCK180 during
Fc receptor-mediated phagocytosis. Both proteins were found
to accumulate at the phagocytic cup, and inhibition of their
function by transfection of dominant negative constructs or by
gene silencing using siRNA impaired the ability of macro-
phages to engulf IgG-coated targets.
FIGURE 8. CrkII is required for the recruitment of active Rac to the phag-
ocytic cup. RAW cells were co-transfected with PBD-YFP and HA-tagged
CrkII and the next day incubated with IgG-opsonized beads for 1 min at
37 °C. A, distribution of PBD-YFP. B, immunostaining for HA. Arrowheads
point to phagocytic cups, whereas asterisks denote beads. Insets show
corresponding DIC images. RAW cells were co-transfected with PBD-YFP
and HA-tagged CrkII(R38K) and then incubated with IgG-opsonized beads
for 1 min. C, distribution of PBD-YFP. D, immunostaining for HA. E, quan-
titation of PBD-YFP at the phagosomal cup. Phagosomal fluorescence
from PBD-YFP was corrected for the background and normalized to cyto-
solic fluorescence for both wild-type (WT) and (R38K)Crk-transfected cells.
Data represent means S.E. of three independent experiments with30
individual determinations/condition.
FIGURE 9. DOCK180 is necessary for the recruitment of active Rac to the
phagocytic cup. RAWcells were transfectedwithDOCK180-specific siRNAor
control siRNA. After 48 h, the cells were transfected by lipofection with YFP-
tagged PBDwhilemaintaining the siRNApresent and the next day incubated
with IgG-opsonizedbeads for 1min at 37 °C.A, distributionof PBD-YFP in cells
transfected with control (non-targeted) siRNA. Arrowheads point to phago-
cytic cups; asterisks denote beads. Insets show corresponding DIC images.
B, distribution of PBD-YFP in cells transfected with siRNA specific for DOCK180.
C, the blot illustrates the effectiveness of the siRNA specific for DOCK180.
Lysates of cells treated with non-targeted (control (Ctrl)) and DOCK180-spe-
cific siRNAwere blottedwith anti-DOCK180 antibody. The graph summarizes
quantitation of PBD-YFP at the phagosomal cup from experiments such as
those in A and B. Phagosomal fluorescence from PBD-YFP was corrected for
background and normalized to cytosolic fluorescence. Data represent
means S.E. of three independent experiments with 40 individual
determinations/condition.
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Two splice variants of Crk have been identified. As in most
cells, CrkII is the predominant isoform in macrophages,
whereas CrkI, which lacks the C-terminal SH3 domain and a
linker region, is expressed at lower levels. It is therefore likely
that the more abundant and versatile isoform, CrkII, is mainly
responsible for the biological effects reported here. CrkL, a
related protein that exhibits 60% amino acid homology toCrkII,
is the product of a distinct gene (10). Like other adaptor pro-
teins, CrkI and II consist of SH2 and SH3 domains and are
therefore capable of bridging tyrosine-phosphorylated proteins
with partners bearing proline-rich motifs (9). Crk isoforms are
likely to be recruited to the activated Fc receptor complex by
phosphotyrosine moieties generated upon stimulation of Src
family kinases or of Syk. Not only are the tyrosines of the recep-
tor ITAM motif phosphorylated, but multiple other phospho-
tyrosines are generated on ancillary proteins recruited to the
receptor complex. These include the ubiquitin ligase Cbl (23)
and the scaffolding proteinGab2 (24). Of note, the SH2 domain
of Crk was reported to bind preferentially to phosphotyrosines
in the context of a pY-X-X-P motif, which is found in both Cbl
and Gab isoforms. Moreover, Gab1 was recently found to asso-
ciate stably with Crk (10, 12).
The middle SH3 domain of CrkII is known to associate with
a proline-rich motif in DOCK180 (16). This interaction most
likely accounts for the recruitment of DOCK180 to sites of
phagocytosis. By contrast, little is known about the function of
the C-terminal SH3 domain of CrkII. Although no binding
partners for this domain have yet been identified, the domain is
clearly biologically important, because it influences cell trans-
formation (25) and cell spreading (26) and may therefore con-
tribute to phagocytosis in additional ways. This SH3 domain
was shown to be essential for the internalization of L. monocy-
togenes by non-phagocytic mammalian cells (12), and a muta-
tion at position 276 had a modest, yet significant, inhibitory
effect on phagocytic efficiency in macrophages (Fig. 2). Addi-
tional studies will be required to define the ligands of this
domain and their functional role.
There is indisputable evidence that Rac plays a key role in the
cytoskeletal remodeling that underlies Fc receptor-mediated
phagocytosis (4, 5, 27). Despite its importance, the mode of
activation of Rac by phagocytic receptors remains poorly
defined. Earlier work implicated members of the Vav family of
nucleotide exchange factors (GEFs). Vav isoforms could be
potentially recruited to the receptor complex by their SH2/SH3
domains and/or by interaction of their PH domain with PIP3
(28). Binding of PIP3 to the PH domain of Vav is thought to
relieve the tonic intramolecular inhibition of the adjacent DH
domain, which is then freed to activate Rac (29, 30). Direct
evidence supporting a role of Vav was obtained by microinjec-
tion of dominant negative alleles of this exchange factor, which
were found to impair phagocytosis of IgG-opsonized particles
by macrophages (6). However, more recent evidence is incon-
sistent with the involvement of Vav in Fc receptor-mediated
phagocytosis. First, although inhibition of phosphatidylinositol
3-kinase results in the arrest of phagocytosis and the stunting of
pseudopod extension, actin polymerization at the base of the
cup is unaffected (31) and the activation of Rac is, paradoxically,
enhanced and prolonged.5 More compelling evidence was
obtained using primary macrophages frommice deficient in all
three isoforms of Vav. In these triple knock-out cells phagocy-
tosis of IgG-opsonized particles proceeded normally (7). It is
therefore likely that the microinjected dominant negative alle-
les may have had effects other than the inhibition of Vav iso-
forms. Together, these observations argue that one or more
GEFs other than Vav are primarily responsible for loading GTP
onto Rac during Fc-mediated phagocytosis.
Our data suggest that the CrkII-DOCK180 complex contrib-
utes to Rac activation at the phagocytic cup during internaliza-
tion of IgG-opsonized particles. Not only are these proteins
recruited to the cup with a spatial and temporal pattern that is
compatible with the initiation of Rac activation, but interfer-
ence with their function impaired the stimulation of Rac. This
was ascertained using PBD-YFP to probe for active Rac/Cdc42
(Figs. 8 and 9) (22). A role for CrkII-DOCK180 in particle
engulfment is not unprecedented. These proteins are also
engaged in the disposal of apoptotic cellsmediated by the phos-
phatidylserine receptor inC. elegans (11, 32) and by integrins in
mammalian cells (33). This commonality of function is intrigu-
ing given the fundamental differences between the phagocyto-
sis of apoptotic and IgG-coated particles (34). The former is an
ongoing process that is characterized by active suppression of
inflammation (34, 35). In contrast, Fc receptor-mediated
phagocytosis is typically associated with induction of the oxi-
dative burst (36) andwith the release of pro-inflammatory cyto-
kines (35). This important distinction had been attributed to
the engagement of different adaptor and GEF systems during
the engulfment of apoptotic and IgG-opsonized particles (11,
37). Our finding that CrkII-DOCK180 is also responsible, at
least in part, for the effects of Fc receptors implies that addi-
tional, parallel pathways must be differentially engaged in both
cases. The source of the pro-inflammatory signals generated by
Fc receptors, which are seemingly unrelated to Vav andCrkII-
DOCK180, must be sought.
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